Hyperthermic intraperitoneal chemotherapy (HIPEC) is a type of cancer treatment in which surgeons apply heated chemotherapy after surgically removing tumors. This innovative method is used to treat mesothelioma, appendix, colorectal and other types of cancer.
Recently, Brian Badgwell, M.D., professor of Surgical Oncology, used HIPEC in a Phase II clinical trial...
Repurposing FDA-approved therapies is a cost-effective way to bring new treatments to patients in need, but identifying those drugs with benefits...
Just as a driver’s night vision improves by simply cleaning the headlights, scientists at The University of Texas MD Anderson Cancer Center...
When Craig Bunk began experiencing severe abdominal pain, blood loss and fatigue, his family doctor thought a stomach ulcer was to blame. Bunk wasn’t so sure.
“My brother Blake died at age 21 from colorectal cancer,” he says. “The disease runs in our family, so I wanted a second opinion.”
Bunk knew just who to call: Patrick Lynch, M.D., a longtime professor of Gastroenterology at MD Anderson. Lynch had treated Blake...
A practice-changing clinical trial conceived and led by MD Anderson investigators showed that metastatic colorectal cancer patients with a...
Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event known...
Three years ago, Stephen Cadmus faced a dilemma. He needed to see a doctor, but he had no health insurance.
To get the medical...
In a first-of-its-kind study, researchers at MD Anderson Cancer Center have demonstrated a benefit in overall survival among epithelial ovarian...
Thanks to the modern era of new chemotherapeutic and biologic agents available for managing their disease, patients with metastatic colorectal...
In the next 15 years, more than one in 10 colon cancers and nearly one in four rectal cancers will be diagnosed in patients younger than the...